Variant report
Variant | esv3402299 |
---|---|
Chromosome Location | chr1:58264867-58265400 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs143558562 | chr1:58264877-58264878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148055942 | chr1:58264878-58264879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368295625 | chr1:58264898-58264899 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547744619 | chr1:58264907-58264908 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114970227 | chr1:58264945-58264946 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563792623 | chr1:58264955-58264956 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566136655 | chr1:58265010-58265011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548917455 | chr1:58265011-58265012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116796788 | chr1:58265166-58265167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534739133 | chr1:58265216-58265217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551583445 | chr1:58265217-58265218 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531399390 | chr1:58265234-58265235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs63240264 | chr1:58265235-58265236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201333470 | chr1:58265255-58265256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs199575852 | chr1:58265256-58265257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs200577535 | chr1:58265257-58265258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547539722 | chr1:58265258-58265259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374995809 | chr1:58265265-58265266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571743909 | chr1:58265277-58265278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536838723 | chr1:58265336-58265337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs6698015 | chr1:58265352-58265353 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs188416718 | chr1:58265353-58265354 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Papillary thyroid carcinoma | 21436994 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Meckel-Gruber syndrome | 21572526 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 19490664 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 22522925 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:58261800-58267400 | Enhancers | Fetal Brain Male | brain |
2 | chr1:58263800-58265200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr1:58264000-58265600 | Weak transcription | Fetal Brain Female | brain |
4 | chr1:58264000-58266400 | Enhancers | Fetal Lung | lung |
5 | chr1:58264600-58268600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr1:58264800-58265800 | Enhancers | Fetal Stomach | stomach |
7 | chr1:58265400-58265600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |